PiperJaffray Maintains Overweight on IGM Biosciences, Raises Price Target to $53

PiperJaffray analyst Edward Tenthoff maintains IGM Biosciences (NASDAQ:IGMS) with a Overweight and raises the price target from $26 to $53.

Benzinga · 01/06/2020 12:57

PiperJaffray analyst Edward Tenthoff maintains IGM Biosciences (NASDAQ:IGMS) with a Overweight and raises the price target from $26 to $53.